\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ none\ \(204\)\
\-\ \\â\\€\\¢\\ 4\\-8\\ mm\\ lesion\\ in\\ the\\ central\\ pons\\ without\\ mass\\ effect\\.\ \(1\)\
\-\ \\â\\€\\¢\\ minimal\\ central\\ enhancement\\ following\\ gadolinium\\ administration\ \(0\)\
\-\ \\â\\€\\¢\\ hemosiderin\\ ring\\ see\\ on\\ t2\\ and\\ flair\\ sequences\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\ \\(cavernous\\ angioma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ avm\ \(0\)\
\-\ \\â\\€\\¢\\ capillary\\ telangectasia\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ melanoma\ \(0\)\
\-\ \\â\\€\\¢\\ cavernous\\ malformation\ \(0\)\
\-\ 66\\ year\\ old\\ woman\\ with\\ facial\\ numbness\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cavernous\\:\\ 0\\.2161902632752844\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.19943819020311299\ \(0\)\
\-\ 4\\-8\\:\\ 0\\.1403073842781525\ \(0\)\
\-\ telangectasia\\:\\ 0\\.1350768011426656\ \(0\)\
\-\ malformation\\:\\ 0\\.12393987827295924\ \(0\)\
\-\ central\\:\\ 0\\.10224114024945305\ \(0\)\
\-\ hemosiderin\\:\\ 0\\.0990585926178186\ \(0\)\
\-\ capillary\\:\\ 0\\.0914787052736043\ \(0\)\
\-\ angioma\\:\\ 0\\.09107010789447598\ \(0\)\
\-\ pons\\:\\ 0\\.08879441438622131\ \(0\)\
\-\ 66\\:\\ 0\\.08356383125073438\ \(0\)\
\-\ melanoma\\:\\ 0\\.07929402050387255\ \(0\)\
\-\ numbness\\:\\ 0\\.0746543313209848\ \(0\)\
\-\ avm\\:\\ 0\\.07401065992005905\ \(0\)\
\-\ gadolinium\\:\\ 0\\.07369717253034076\ \(0\)\
\-\ ring\\:\\ 0\\.07220602431832558\ \(0\)\
\-\ flair\\:\\ 0\\.07123052043664703\ \(0\)\
\-\ facial\\:\\ 0\\.06755730902076908\ \(0\)\
\-\ sequences\\:\\ 0\\.06488171548738203\ \(0\)\
\-\ administration\\:\\ 0\\.06450291390733036\ \(0\)\
\-\ minimal\\:\\ 0\\.06117236309819632\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.057382476512852304\ \(0\)\
\-\ mm\\:\\ 0\\.05713082103263646\ \(0\)\
\-\ effect\\:\\ 0\\.05501015005580445\ \(0\)\
\-\ cerebral\\:\\ 0\\.05382630003207401\ \(0\)\
\-\ see\\:\\ 0\\.04636758565870524\ \(0\)\
\-\ following\\:\\ 0\\.04409595921638451\ \(0\)\
\-\ t2\\:\\ 0\\.0439743412500064\ \(0\)\
\-\ enhancement\\:\\ 0\\.041645250293146106\ \(0\)\
\-\ metastatic\\:\\ 0\\.039111080065747095\ \(0\)\
\-\ none\\:\\ 0\\.03854035467105466\ \(0\)\
\-\ without\\:\\ 0\\.03658205757014837\ \(0\)\
\-\ woman\\:\\ 0\\.03588914449979829\ \(0\)\
\-\ lesion\\:\\ 0\\.03164645865455372\ \(0\)\
\-\ mass\\:\\ 0\\.02160838194450117\ \(0\)\
\-\ year\\:\\ 0\\.01738373216859845\ \(0\)\
\-\ old\\:\\ 0\\.015907901761131903\ \(0\)\
\-\ on\\:\\ 0\\.01316165477028051\ \(0\)\
\-\ \\(\\:\\ 0\\.013133849568070191\ \(0\)\
\-\ \\)\\:\\ 0\\.012973412583878274\ \(0\)\
\-\ in\\:\\ 0\\.007661767820731908\ \(0\)\
\-\ and\\:\\ 0\\.0032728910133130625\ \(0\)\
\-\ the\\:\\ 0\\.002513623358247742\ \(0\)\
\-\ with\\:\\ 0\\.0021273486561798134\ \(0\)\
\-\ \\.\\:\\ 0\\.0006454461108608414\ \(0\)\
